Growth and clonal expansion of a highly reactive CD8 clone and backtransfer to patients resulted in a dramatic homing of re-injected cells at metastatic sites, but this increased tumour cell recognition by T cells did not propagate into clinical benefit to the patients (Yee et al, 2002), since antigen-negative tumour cells were out of target and escaped. Here, CD8A is linked to neoplasm.